Hikma Pharma to meet investors for potential dollar bond -leads
DUBAI, March 25 (Reuters) - Hikma Pharmaceuticals Plc (LSE: HIK.L - news) , a drugs group founded in Jordan in 1978, has picked four banks to arrange a series of fixed income meetings starting Friday for a potential benchmark dollar bond, a document from lead arrangers showed.
The company has picked Citigroup (NYSE: C - news) , Barclays (LSE: BARC.L - news) , HSBC and National Bank (NYSE: NBHC - news) of Abu Dhabi to arrange investor meetings in Europe and the Middle East, the document stated.
Hikma, rated BB+ Standard (Other OTC: SNDH - news) and Poor's and Ba1 by Moody's, joined Britain's benchmark FTSE 100 equity index in March. Getting into the FTSE 100 can often fuel further demand for a company's shares, since funds that track the FTSE or invest in the index can then add that stock to their portfolio. (Reporting by Archana Narayanan; editing by Matt Smith)